GGrantIndex
Sort

17,054 grants matching genome editing

Systematic Genetic Dissection of Human Erythropoiesis

$398,250
Vijay Ganesh Sankaran · Boston Children'S Hospital · R01 · FY2018 · DK

Regulation of the telomerase RNA component in hematopoiesis

$398,250
Suneet Agarwal · Boston Children'S Hospital · R01 · FY2019 · DK

Single molecule and biophysical studies of nucleic acid remodeling

$398,250
Taekjip Ha · Boston Children'S Hospital · R35 · FY2024 · GM

Regulation of the telomerase RNA component in hematopoiesis

$398,250
Suneet Agarwal · Boston Children'S Hospital · R01 · FY2020 · DK

Single molecule and biophysical studies of nucleic acid remodeling

$398,250
Taekjip Ha · Boston Children'S Hospital · R35 · FY2025 · GM

Systematic Genetic Dissection of Human Erythropoiesis

$398,250
Vijay Ganesh Sankaran · Boston Children'S Hospital · R01 · FY2021 · DK

Systematic Genetic Dissection of Human Erythropoiesis

$398,250
Vijay Ganesh Sankaran · Boston Children'S Hospital · R01 · FY2020 · DK

Single molecule and biophysical studies of nucleic acid remodeling

$398,250
Taekjip Ha · Boston Children'S Hospital · R35 · FY2023 · GM

Network-based prediction and validation of causal schizophrenia genes and variants

$398,193
Manolis Kellis · Massachusetts Institute Of Technology · R01 · FY2020 · MH

Epigenetic enhancer control in maintaining homeostasis and preventing carcinogenesis in the epidermis

$398,067
Brian Capell · University Of Pennsylvania · R01 · FY2023 · AR

Engineered Cas9 Nucleases with Single-Genomic-Site Precision for CYBB Correction

$398,059
Scot A Wolfe · Univ Of Massachusetts Med Sch Worcester · R01 · FY2018 · GM

Engineered Cas9 Nucleases with Single-Genomic-Site Precision for CYBB Correction

$398,059
Scot A Wolfe · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · GM

Chimeric antigen receptor-modified iNKT cell therapy for CD7+ malignancies

$398,040
Xianzheng Zhou · Tinkeso Therapeutics Inc · R43 · FY2023 · CA

Full-length sequencing of individual RNAs from heterogeneous samples

$398,040
William S Agnew · Phaeno Inc · R43 · FY2022 · HG

Regulation of Polyadenylation: the U1A/U1snRNP Paradigm

$397,991
Rutgers The St Univ Of Nj New Brunswick · R01 · FY2004 · GM

Systematic Genetic Dissection of Human Erythropoiesis

$397,875
Vijay Ganesh Sankaran · Boston Children'S Hospital · R01 · FY2015 · DK

Editing CG and non-CG DNA methylation to identify genomic elements that regulate gene expression

$397,807
Hani Goodarzi · University Of California, San Francisco · R01 · FY2023 · HG

Investigation of Self-Nucleic Acids as a Trigger for Neuroinflammation

$397,688
Hachung Chung · Columbia University Health Sciences · R01 · FY2024 · NS

Mechanisms of immune evasion in T-cell acute lymphoblastic leukemia and its therapeutic implications

$397,633
Birgit Knoechel · Dana-Farber Cancer Inst · R01 · FY2023 · CA

Regulation of stem-like CD8+ T cells and their role in immunotherapy

$397,630
Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2023 · CA

A Comprehensive Catalog of Dnasel Hypersensitive Sites

$397,622
John A Stamatoyannopoulos · University Of Washington · U54 · FY2015 · HG

(PQ1) The role of cell-to-cell variation in the penetrance of heritable mutant RAS hypodermal neoplasias

$397,573
Alexander Richard Mendenhall · University Of Washington · R01 · FY2018 · CA

Targeted Infusion Project Development of a CRISPR Cas9 based gene editing technology curriculum at Tennessee State University

$397,565
Sonali Roy · Tennessee State University · · FY2022 · EDU

Epigenetic Dysregulation in Diabetic Enteric Neuropathy

$397,500
Tamas Ordog · Mayo Clinic Rochester · P01 · FY2015 · DK

Retinoic acid-dependent epigenetic and transcriptional mechanisms controlling heart development

$397,500
Joshua Waxman · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · HL